Suppr超能文献

一种新型的核黄素合酶抑制剂，由1,3,6,8 - 四羟基 - 2,7 - 萘啶氧化为四氮杂苝六酮衍生物而得到。

A novel lumazine synthase inhibitor derived from oxidation of 1,3,6,8-tetrahydroxy-2,7-naphthyridine to a tetraazaperylenehexaone derivative.

作者信息

Zhang Yanlei, Illarionov Boris, Bacher Adelbert, Fischer Markus, Georg Gunda I, Ye Qi-Zhuang, Vander Velde David, Fanwick Phillip E, Song Yunlong, Cushman Mark

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, and The Purdue Cancer Center, Purdue University, West Lafayette, Indiana 47907, USA.

出版信息

J Org Chem. 2007 Apr 13;72(8):2769-76. doi: 10.1021/jo062246d. Epub 2007 Mar 10.

DOI:10.1021/jo062246d
PMID:17348709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2526313/
Abstract

Air oxidation of 1,3,6,8-tetrahydroxy-2,7-naphthyridine afforded 2,5,8,11-tetraaza-5,11-dihydro-4,10-dihydroxyperylene-1,3,6,7,9,12-hexaone. X-ray crystallography of the product revealed that it exists in the meso form in the solid state. The mechanism of product formation most likely involves oxidative phenolic coupling and oxidation. The product proved to be a competitive inhibitor of Schizosaccharomyces pombe lumazine synthase with a Ki of 66+/-13 microM in Tris buffer and 22+/-4 microM in phosphate buffer. This is significantly more potent than the reactant (Ki 350+/-76 microM, competitive inhibition), which had previously been identified as a lumazine synthase inhibitor by high-throughput screening. Ab initio calculations indicate that the meso form is slightly less stable than the enantiomeric form, and that the two forms interconvert rapidly at room temperature.

摘要

1,3,6,8 - 四羟基 - 2,7 - 萘啶的空气氧化反应生成了2,5,8,11 - 四氮杂 - 5,11 - 二氢 - 4,10 - 二羟基苝 - 1,3,6,7,9,12 - 六酮。产物的X射线晶体学分析表明，它在固态时以内消旋形式存在。产物形成的机制很可能涉及氧化酚偶联和氧化反应。该产物被证明是粟酒裂殖酵母核黄素合酶的竞争性抑制剂，在Tris缓冲液中的Ki为66±13 μM，在磷酸盐缓冲液中的Ki为22±4 μM。这比反应物（Ki 350±76 μM，竞争性抑制）的活性显著更高，反应物之前已通过高通量筛选被鉴定为核黄素合酶抑制剂。从头算计算表明，内消旋形式比对映体形式稍微不稳定，并且这两种形式在室温下会快速相互转化。

相似文献

1
A novel lumazine synthase inhibitor derived from oxidation of 1,3,6,8-tetrahydroxy-2,7-naphthyridine to a tetraazaperylenehexaone derivative.一种新型的核黄素合酶抑制剂，由1,3,6,8 - 四羟基 - 2,7 - 萘啶氧化为四氮杂苝六酮衍生物而得到。
J Org Chem. 2007 Apr 13;72(8):2769-76. doi: 10.1021/jo062246d. Epub 2007 Mar 10.
2
A new series of N-[2,4-dioxo-6-d-ribitylamino-1,2,3,4-tetrahydropyrimidin-5-yl]oxalamic acid derivatives as inhibitors of lumazine synthase and riboflavin synthase: design, synthesis, biochemical evaluation, crystallography, and mechanistic implications.作为鲁核黄素合酶和核黄素合酶抑制剂的新型N-[2,4-二氧代-6-D-核糖基氨基-1,2,3,4-四氢嘧啶-5-基]草氨酸衍生物系列：设计、合成、生化评价、晶体学及作用机制研究
J Org Chem. 2008 Apr 4;73(7):2715-24. doi: 10.1021/jo702631a. Epub 2008 Mar 11.
3
Synthesis and enzyme inhibitory activity of the s-nucleoside analogue of the ribitylaminopyrimidine substrate of lumazine synthase and product of riboflavin synthase.核黄素合酶的产物及鲁米诺合酶的核糖醇氨基嘧啶底物的S-核苷类似物的合成与酶抑制活性
J Org Chem. 2007 Sep 14;72(19):7167-75. doi: 10.1021/jo0709495. Epub 2007 Aug 16.
4
Discovery and development of a small molecule library with lumazine synthase inhibitory activity.具有鲁玛嗪合酶抑制活性的小分子文库的发现与开发。
J Org Chem. 2009 Aug 7;74(15):5123-34. doi: 10.1021/jo900238q.
5
Design, synthesis, and evaluation of 9-D-ribitylamino-1,3,7,9-tetrahydro-2,6,8-purinetriones bearing alkyl phosphate and alpha,alpha-difluorophosphonate substituents as inhibitors of tiboflavin synthase and lumazine synthase.作为核黄素合酶和鲁棒嗪合酶抑制剂的带有磷酸烷基酯和α,α-二氟膦酸酯取代基的9-D-核糖氨基-1,3,7,9-四氢-2,6,8-嘌呤三酮的设计、合成与评价
J Org Chem. 2004 Feb 6;69(3):601-12. doi: 10.1021/jo030278k.
6
A new series of 3-alkyl phosphate derivatives of 4,5,6,7-tetrahydro-1-D-ribityl-1H-pyrazolo[3,4-d]pyrimidinedione as inhibitors of lumazine synthase: design, synthesis, and evaluation.作为鲁马嗪合酶抑制剂的4,5,6,7-四氢-1-D-核糖基-1H-吡唑并[3,4-d]嘧啶二酮的一系列新型3-烷基磷酸酯衍生物：设计、合成与评价
J Org Chem. 2007 Sep 14;72(19):7176-84. doi: 10.1021/jo070982r. Epub 2007 Aug 18.
7
A high-throughput screen utilizing the fluorescence of riboflavin for identification of lumazine synthase inhibitors.一种利用核黄素荧光进行鲁玛嗪合酶抑制剂鉴定的高通量筛选方法。
Anal Biochem. 2005 Mar 1;338(1):124-30. doi: 10.1016/j.ab.2004.11.033.
8
Incorporation of an amide into 5-phosphonoalkyl-6-D-ribitylaminopyrimidinedione lumazine synthase inhibitors results in an unexpected reversal of selectivity for riboflavin synthase vs lumazine synthase.将酰胺基团引入5-膦酰基烷基-6-D-核糖基氨基嘧啶二酮鲁玛嗪合酶抑制剂中，会导致对核黄素合酶与鲁玛嗪合酶的选择性出现意外逆转。
J Org Chem. 2002 Oct 4;67(20):6871-7. doi: 10.1021/jo020144r.
9
Design and synthesis of 6-(6-D-ribitylamino-2,4-dihydroxypyrimidin-5-yl)-1-hexyl phosphonic acid, a potent inhibitor of lumazine synthase.
Bioorg Med Chem Lett. 1999 Jan 4;9(1):39-42. doi: 10.1016/s0960-894x(98)00687-8.
10
Structural basis of charge transfer complex formation by riboflavin bound to 6,7-dimethyl-8-ribityllumazine synthase.与6,7-二甲基-8-核糖基芦竹碱合酶结合的核黄素形成电荷转移复合物的结构基础。
Eur J Biochem. 2004 Aug;271(15):3208-14. doi: 10.1111/j.1432-1033.2004.04253.x.

引用本文的文献

1
Cellular Stress-Induced Metabolites in .细胞应激诱导代谢物在. 中
J Nat Prod. 2022 Nov 25;85(11):2626-2640. doi: 10.1021/acs.jnatprod.2c00706. Epub 2022 Nov 8.
2
Towards Nitrogen-Rich N-Heteropolycycles: Synthesis of Octaazaperopyrenes (OAPP).迈向富氮氮杂多环化合物：八氮杂苝（OAPP）的合成。
Chemistry. 2022 Mar 22;28(17):e202200129. doi: 10.1002/chem.202200129. Epub 2022 Feb 28.
3
Discovery of 8-Amino-Substituted 2-Phenyl-2,7-Naphthyridinone Derivatives as New c-Kit/VEGFR-2 Kinase Inhibitors.发现 8-氨基取代的 2-苯基-2,7-萘啶酮衍生物作为新型 c-Kit/VEGFR-2 激酶抑制剂。
Molecules. 2019 Dec 5;24(24):4461. doi: 10.3390/molecules24244461.

本文引用的文献

1
Design, synthesis, and biochemical evaluation of 1,5,6,7-tetrahydro-6,7-dioxo-9-D-ribitylaminolumazines bearing alkyl phosphate substituents as inhibitors of lumazine synthase and riboflavin synthase.带有磷酸烷基酯取代基的1,5,6,7-四氢-6,7-二氧代-9-D-核糖基氨基蝶啶作为蝶啶合酶和核黄素合酶抑制剂的设计、合成及生化评价
J Org Chem. 2005 Sep 30;70(20):8162-70. doi: 10.1021/jo051332v.
2
Crystal structure of an archaeal pentameric riboflavin synthase in complex with a substrate analog inhibitor: stereochemical implications.与底物类似物抑制剂结合的古菌五聚体核黄素合酶的晶体结构：立体化学意义
J Biol Chem. 2006 Jan 13;281(2):1224-32. doi: 10.1074/jbc.M509440200. Epub 2005 Nov 4.
3
Crystal structure of lumazine synthase from Mycobacterium tuberculosis as a target for rational drug design: binding mode of a new class of purinetrione inhibitors.结核分枝杆菌中鲁比嗪合酶的晶体结构作为合理药物设计的靶点：一类新型嘌呤三酮抑制剂的结合模式
Biochemistry. 2005 Mar 1;44(8):2746-58. doi: 10.1021/bi047848a.
4
A high-throughput screen utilizing the fluorescence of riboflavin for identification of lumazine synthase inhibitors.一种利用核黄素荧光进行鲁玛嗪合酶抑制剂鉴定的高通量筛选方法。
Anal Biochem. 2005 Mar 1;338(1):124-30. doi: 10.1016/j.ab.2004.11.033.
5
Aerobic oxidation of 2,3,6-trimethylphenol to trimethyl-1,4-benzoquinone with copper(II) chloride as catalyst in ionic liquid and structure of the active species.以氯化铜（II）为催化剂，在离子液体中2,3,6-三甲基苯酚有氧氧化制备三甲基-1,4-苯醌及活性物种的结构
J Am Chem Soc. 2004 Aug 11;126(31):9550-1. doi: 10.1021/ja0391964.
6
Structural basis of charge transfer complex formation by riboflavin bound to 6,7-dimethyl-8-ribityllumazine synthase.与6,7-二甲基-8-核糖基芦竹碱合酶结合的核黄素形成电荷转移复合物的结构基础。
Eur J Biochem. 2004 Aug;271(15):3208-14. doi: 10.1111/j.1432-1033.2004.04253.x.
7
Oxidation mechanism of phenols by dicopper-dioxygen (Cu(2)/O(2)) complexes.二铜-双氧（Cu(2)/O(2)）配合物对酚类的氧化机理
J Am Chem Soc. 2003 Sep 10;125(36):11027-33. doi: 10.1021/ja029380+.
8
Mechanistic features of lignin peroxidase-catalyzed oxidation of substituted phenols and 1,2-dimethoxyarenes.
J Biol Chem. 2003 Oct 10;278(41):39726-34. doi: 10.1074/jbc.M303918200. Epub 2003 Jul 11.
9
Enantioselective oxidative biaryl coupling reactions catalyzed by 1,5-diazadecalin metal complexes: efficient formation of chiral functionalized BINOL derivatives.1,5-二氮杂萘金属配合物催化的对映选择性氧化联芳基偶联反应：手性官能化联萘酚衍生物的高效合成
J Org Chem. 2003 Jul 11;68(14):5500-11. doi: 10.1021/jo0340206.
10
A structure-based model of the reaction catalyzed by lumazine synthase from Aquifex aeolicus.嗜热栖热菌中鲁比嗪合酶催化反应的基于结构的模型。
J Mol Biol. 2003 Apr 18;328(1):167-82. doi: 10.1016/s0022-2836(03)00186-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验